1,220 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Atala Financial Inc

Atala Financial Inc purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, Holdings Channel reports. The firm purchased 1,220 shares of the biotechnology company’s stock, valued at approximately $725,000.

A number of other large investors also recently modified their holdings of AXON. Geode Capital Management LLC lifted its holdings in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after buying an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC lifted its position in shares of Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after buying an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at $200,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the transaction, the president now directly owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This represents a 0.70 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,146 shares of company stock worth $3,262,847 over the last 90 days. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Down 4.2 %

Shares of NASDAQ:AXON opened at $534.56 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm’s 50-day simple moving average is $595.56 and its 200-day simple moving average is $532.90. The company has a market cap of $40.96 billion, a price-to-earnings ratio of 138.13, a PEG ratio of 5.17 and a beta of 1.12.

Analyst Ratings Changes

Several research firms have recently weighed in on AXON. Needham & Company LLC reissued a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.